Svetlana, founder of Precision Oncology Consulting, brings 18 years of international experience in diagnostics and genomics from companies like Roche Diagnostics, Illumina, and C2i Genomics. Her focus and passion are on the clinical implementation of advanced molecular methods, including whole-genome/transcriptome sequencing and MRD testing in oncology.

Svetlana holds advanced degrees in Biochemistry, Molecular Biology, and Marketing Management, and has recently completed Harvard Medical School's HMX Pro courses in Clinical Drug Development and Pharmacology. She is about to start a Market Access Course at EADA Business School.

Precision Oncology Consulting enables precision oncology by supporting biotech, pharma, academic centres, and diagnostic/therapeutic companies in bringing next-generation molecular solutions to market. They offer integrated services, leveraging the extensive experience in expert networks, scientific advisory board execution, development of market access dossiers and strategies, while supporting diverse genomics-based technologies.